BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 36251117)

  • 21. Comprehensive Transcriptomic and Genomic Profiling of Subtypes of Follicular Variant of Papillary Thyroid Carcinoma.
    Song YS; Won JK; Yoo SK; Jung KC; Kim MJ; Kim SJ; Cho SW; Lee KE; Yi KH; Seo JS; Park YJ
    Thyroid; 2018 Nov; 28(11):1468-1478. PubMed ID: 30226444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
    Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
    Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Profile and Clinicopathologic Features of Follicular Variant Papillary Thyroid Carcinoma.
    Sohn SY; Lee JJ; Lee JH
    Pathol Oncol Res; 2020 Apr; 26(2):927-936. PubMed ID: 30900082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BRAF V600E mutation in papillary thyroid carcinoma: significant association with node metastases and extra thyroidal invasion.
    Chakraborty A; Narkar A; Mukhopadhyaya R; Kane S; D'Cruz A; Rajan MG
    Endocr Pathol; 2012 Jun; 23(2):83-93. PubMed ID: 22105775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Shift in Molecular Drivers of Papillary Thyroid Carcinoma Following the 2017 World Health Organization Classification: Characterization of 554 Consecutive Tumors With Emphasis on BRAF-Negative Cases.
    Hang JF; Chen JY; Kuo PC; Lai HF; Lee TL; Tai SK; Kuo CS; Chen HS; Li WS; Li CF
    Mod Pathol; 2023 Sep; 36(9):100242. PubMed ID: 37307878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular characterization of tumors meeting diagnostic criteria for the non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
    Pool C; Walter V; Bann D; Goldenberg D; Broach J; Hennessy M; Cottrill E; Washburn E; Williams N; Crist H; Imamura Y; Warrick JI
    Virchows Arch; 2019 Mar; 474(3):341-351. PubMed ID: 30645670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expanding the spectrum of thyroid carcinoma with somatic DICER1 mutation: a survey of 829 thyroid carcinomas using MSK-IMPACT next-generation sequencing platform.
    Ghossein CA; Dogan S; Farhat N; Landa I; Xu B
    Virchows Arch; 2022 Feb; 480(2):293-302. PubMed ID: 34580763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PD-L1 and thyroid cytology: A possible diagnostic and prognostic marker.
    Dell'Aquila M; Granitto A; Martini M; Capodimonti S; Cocomazzi A; Musarra T; Fiorentino V; Pontecorvi A; Lombardi CP; Fadda G; Pantanowitz L; Larocca LM; Rossi ED
    Cancer Cytopathol; 2020 Mar; 128(3):177-189. PubMed ID: 31821747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrofollicular Variant of Follicular Thyroid Carcinoma (MV-FTC) with a Somatic DICER1 Gene Mutation: Case Report and Review of the Literature.
    Hellgren LS; Hysek M; Jatta K; Zedenius J; Juhlin CC
    Head Neck Pathol; 2021 Jun; 15(2):668-675. PubMed ID: 32712880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Follicular variant of papillary carcinoma: reproducibility of histologic diagnosis and utility of HBME-1 immunohistochemistry and BRAF mutational analysis as diagnostic adjuncts.
    Wallander M; Layfield LJ; Jarboe E; Emerson L; Liu T; Thaker H; Holden J; Tripp S
    Appl Immunohistochem Mol Morphol; 2010 May; 18(3):231-5. PubMed ID: 20042852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DICER1 Mutations and Differentiated Thyroid Carcinoma: Evidence of a Direct Association.
    Rutter MM; Jha P; Schultz KA; Sheil A; Harris AK; Bauer AJ; Field AL; Geller J; Hill DA
    J Clin Endocrinol Metab; 2016 Jan; 101(1):1-5. PubMed ID: 26555935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity.
    Liu J; Singh B; Tallini G; Carlson DL; Katabi N; Shaha A; Tuttle RM; Ghossein RA
    Cancer; 2006 Sep; 107(6):1255-64. PubMed ID: 16900519
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Ricarte-Filho JC; Casado-Medrano V; Reichenberger E; Spangler Z; Scheerer M; Isaza A; Baran J; Patel T; MacFarland SP; Brodeur GM; Stewart DR; Baloch Z; Bauer AJ; Wasserman JD; Franco AT
    Front Endocrinol (Lausanne); 2023; 14():1083382. PubMed ID: 36896180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Follicular histotypes of oncocytic thyroid carcinomas do not carry mutations of the BRAF hot-spot.
    Musholt PB; Musholt TJ; Morgenstern SC; Worm K; Sheu SY; Schmid KW
    World J Surg; 2008 May; 32(5):722-8. PubMed ID: 18235983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma.
    Castro P; Rebocho AP; Soares RJ; Magalhães J; Roque L; Trovisco V; Vieira de Castro I; Cardoso-de-Oliveira M; Fonseca E; Soares P; Sobrinho-Simões M
    J Clin Endocrinol Metab; 2006 Jan; 91(1):213-20. PubMed ID: 16219715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyroid Nodules and Follicular Cell-Derived Thyroid Carcinomas in Children.
    Slack JC; Hollowell M; Barletta JA
    Endocr Pathol; 2023 Jun; 34(2):165-175. PubMed ID: 37160531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of Thyroid Cancer and Multinodular Goiter Risk in the DICER1 Syndrome: A Family-Based Cohort Study.
    Khan NE; Bauer AJ; Schultz KAP; Doros L; Decastro RM; Ling A; Lodish MB; Harney LA; Kase RG; Carr AG; Rossi CT; Field A; Harris AK; Williams GM; Dehner LP; Messinger YH; Hill DA; Stewart DR
    J Clin Endocrinol Metab; 2017 May; 102(5):1614-1622. PubMed ID: 28323992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BRAF and RAS Mutational Status in Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features and Invasive Subtype of Encapsulated Follicular Variant of Papillary Thyroid Carcinoma in Korea.
    Kim M; Jeon MJ; Oh HS; Park S; Kim TY; Shong YK; Kim WB; Kim K; Kim WG; Song DE
    Thyroid; 2018 Apr; 28(4):504-510. PubMed ID: 29439609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and Molecular Characteristics May Alter Treatment Strategies of Thyroid Malignancies in DICER1 Syndrome.
    van der Tuin K; de Kock L; Kamping EJ; Hannema SE; Pouwels MM; Niedziela M; van Wezel T; Hes FJ; Jongmans MC; Foulkes WD; Morreau H
    J Clin Endocrinol Metab; 2019 Feb; 104(2):277-284. PubMed ID: 30260442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative BRAF V600E immunohistochemical expression in differentiated thyroid tumors with papillary features.
    Wahid MHA; Almudhafar RH
    J Med Life; 2022 Apr; 15(4):520-525. PubMed ID: 35646190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.